NASDAQ : CPRX
Catalyst Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 31.49 USD (Jul 15, 2026, 4:00 PM EDT) · Market cap 3.85B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Catalyst Pharmaceuticals, Inc. (CPRX) reported revenue of 596.96M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 596.96M | 588.99M | 491.73M | 398.20M | 214.20M | 140.83M |
| Cost of Revenue | 95.30M | 99.96M | 81.49M | 145.12M | 54.18M | 38.82M |
| Gross Profit | 501.66M | 489.03M | 410.24M | 253.09M | 160.02M | 102.01M |
| Selling, General & Admin | 196.16M | 193.75M | 177.74M | 133.71M | 57.09M | 49.63M |
| Amortization of Goodwill & Intangibles | 37.86M | 37.50M | 37.38M | 32.56M | 1.10M | |
| Operating Expenses | 234.01M | 231.25M | 215.12M | 166.28M | 58.18M | 49.63M |
| Operating Income | 267.64M | 257.78M | 195.12M | 86.81M | 101.84M | 52.38M |
| Interest & Investment Income | 25.74M | 24.77M | 16.06M | 282.00K | ||
| Other Non Operating Income (Expenses) | 4.67M | 2.88M | ||||
| EBT Excluding Unusual Items | 293.38M | 282.54M | 211.19M | 91.49M | 104.72M | 52.67M |
| Gain (Loss) on Sale of Investments | 3.08M | 972.00K | 5.08M | 3.02M | ||
| Pretax Income | 296.46M | 283.51M | 216.26M | 94.51M | 104.72M | 52.67M |
| Income Tax Expense | 75.14M | 69.19M | 52.37M | 23.10M | 21.64M | 13.19M |
| Net Income | 221.32M | 214.33M | 163.89M | 71.41M | 83.08M | 39.48M |
| Net Income to Common | 221.32M | 214.33M | 163.89M | 71.41M | 83.08M | 39.48M |
| Shares Outstanding (Basic) | 122.49M | 122.29M | 118.46M | 106.28M | 103.37M | 103.38M |
| Shares Outstanding (Diluted) | 127.24M | 127.26M | 124.94M | 113.75M | 111.38M | 107.80M |
| EPS (Basic) | 1.81 | 1.75 | 1.38 | 0.67 | 0.80 | 0.38 |
| EPS (Diluted) | 1.73 | 1.68 | 1.31 | 0.63 | 0.75 | 0.37 |
| Free Cash Flow | 208.13M | 208.61M | 239.25M | -54.92M | 106.02M | 59.35M |
| Free Cash Flow Per Share | 1.64 | 1.64 | 1.92 | -0.48 | 0.95 | 0.55 |
| Gross Margin | 84.04% | 83.03% | 83.43% | 63.56% | 74.70% | 72.44% |
| Operating Margin | 44.83% | 43.77% | 39.68% | 21.80% | 47.54% | 37.20% |
| Profit Margin | 37.08% | 36.39% | 33.33% | 17.93% | 38.78% | 28.04% |
| Free Cash Flow Margin | 34.87% | 35.42% | 48.66% | -13.79% | 49.49% | 42.14% |
| EBITDA | 305.83M | 295.65M | 232.90M | 119.69M | 103.08M | 52.58M |
| EBITDA Margin | 51.23% | 50.20% | 47.36% | 30.06% | 48.12% | 37.33% |
| D&A For EBITDA | 38.19M | 37.87M | 37.77M | 32.88M | 1.24M | 192.00K |
| EBIT | 267.64M | 257.78M | 195.12M | 86.81M | 101.84M | 52.38M |
| EBIT Margin | 44.83% | 43.77% | 39.68% | 21.80% | 47.54% | 37.20% |
| Effective Tax Rate | 25.34% | 24.40% | 24.22% | 24.44% | 20.66% | 25.04% |
| Revenue as Reported | 596.96M | 588.99M | 491.73M | 398.20M | 214.20M | 140.83M |
| Advertising Expenses | 13.00M | 10.00M | 9.10M | 3.30M | 2.90M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 755.86M | 709.17M | 517.55M | 137.64M | 298.39M | 171.44M |
| Short-Term Investments | 19.82M | |||||
| Cash & Short-Term Investments | 755.86M | 709.17M | 517.55M | 137.64M | 298.39M | 191.27M |
| Accounts Receivable | 130.83M | 126.48M | 65.48M | 53.65M | 10.79M | 6.72M |
| Other Receivables | 472.00K | 1.79M | 536.00K | |||
| Receivables | 131.31M | 128.27M | 66.01M | 53.65M | 10.79M | 6.72M |
| Inventory | 34.93M | 37.17M | 19.54M | 15.64M | 6.80M | 7.87M |
| Prepaid Expenses | 15.58M | 17.39M | 20.00M | 12.05M | 4.32M | 3.92M |
| Other Current Assets | 2.72M | 2.04M | 505.00K | 351.00K | 489.00K | 327.00K |
| Total Current Assets | 940.39M | 894.03M | 623.61M | 219.33M | 320.81M | 210.11M |
| Property, Plant & Equipment | 2.85M | 2.97M | 3.58M | 3.70M | 3.62M | 3.98M |
| Long-Term Investments | 27.29M | 22.54M | 21.56M | 16.49M | ||
| Other Intangible Assets | 121.97M | 131.67M | 156.67M | 194.05M | 32.47M | |
| Long-Term Deferred Tax Assets | 55.11M | 52.77M | 45.98M | 36.54M | 18.74M | 23.70M |
| Other Long-Term Assets | 9.00K | |||||
| Total Assets | 1.15B | 1.10B | 851.41M | 470.11M | 375.63M | 237.79M |
| Accounts Payable | 7.15M | 11.20M | 16.59M | 14.79M | 3.98M | 2.77M |
| Accrued Expenses | 26.54M | 61.66M | 53.85M | 40.29M | 27.83M | 21.95M |
| Current Portion of Leases | 446.00K | 437.00K | 402.00K | 369.00K | 337.00K | 308.00K |
| Current Income Taxes Payable | 19.63M | 1.40M | 894.00K | 729.00K | 8.70M | 79.00K |
| Other Current Liabilities | 78.63M | 72.46M | 48.94M | 19.88M | 16.75M | 1.96M |
| Total Current Liabilities | 132.40M | 147.15M | 120.68M | 76.06M | 57.59M | 27.06M |
| Long-Term Leases | 2.23M | 2.35M | 2.79M | 3.19M | 3.56M | 3.89M |
| Other Long-Term Liabilities | 280.00K | 209.00K | 315.00K | 2.98M | 14.06M | |
| Total Liabilities | 134.91M | 149.71M | 123.78M | 82.23M | 75.21M | 30.96M |
| Common Stock | 122.00K | 123.00K | 121.00K | 107.00K | 105.00K | 103.00K |
| Additional Paid-In Capital | 489.22M | 479.96M | 442.29M | 266.49M | 250.43M | 233.19M |
| Retained Earnings | 523.35M | 474.19M | 285.16M | 121.27M | 49.86M | -26.31M |
| Comprehensive Income & Other | 8.00K | 64.00K | 14.00K | 24.00K | -148.00K | |
| Shareholders' Equity | 1.01B | 954.27M | 727.63M | 387.88M | 300.42M | 206.83M |
| Total Liabilities & Equity | 1.15B | 1.10B | 851.41M | 470.11M | 375.63M | 237.79M |
| Total Debt | 2.68M | 2.79M | 3.19M | 3.56M | 3.89M | 4.20M |
| Net Cash (Debt) | 753.18M | 706.38M | 514.37M | 134.08M | 294.50M | 187.06M |
| Net Cash Per Share | 5.92 | 5.55 | 4.12 | 1.18 | 2.64 | 1.74 |
| Filing Date Shares Outstanding | 122.38M | 122.12M | 121.45M | 117.86M | 105.65M | 102.74M |
| Total Common Shares Outstanding | 122.18M | 122.51M | 120.88M | 107.12M | 105.26M | 102.99M |
| Working Capital | 807.99M | 746.88M | 502.93M | 143.27M | 263.22M | 183.04M |
| Book Value Per Share | 8.29 | 7.79 | 6.02 | 3.62 | 2.85 | 2.01 |
| Tangible Book Value | 890.73M | 822.59M | 570.96M | 193.83M | 267.95M | 206.83M |
| Tangible Book Value Per Share | 7.29 | 6.71 | 4.72 | 1.81 | 2.55 | 2.01 |
| Machinery | 1.14M | 1.11M | 1.05M | 494.00K | 273.00K | 254.00K |
| Leasehold Improvements | 991.00K | 991.00K | 991.00K | 991.00K | 980.00K | 980.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 221.32M | 214.33M | 163.89M | 71.41M | 83.08M | 39.48M |
| Depreciation & Amortization | 38.19M | 37.87M | 37.77M | 32.88M | 1.24M | 192.00K |
| Asset Writedown & Restructuring Costs | 81.51M | |||||
| Loss (Gain) From Sale of Investments | -3.08M | -972.00K | -5.08M | -3.02M | 762.00K | |
| Stock-Based Compensation | 25.19M | 24.78M | 22.25M | 14.25M | 7.91M | 6.07M |
| Other Operating Activities | -6.53M | -6.44M | -9.95M | -16.11M | 9.33M | 9.60M |
| Change in Accounts Receivable | -59.57M | -61.00M | -11.96M | -43.08M | -3.82M | -632.00K |
| Change in Inventory | -15.62M | -18.09M | -3.90M | -4.74M | 1.06M | -3.22M |
| Change in Accounts Payable | -4.05M | -5.39M | 1.80M | 10.82M | 1.21M | -1.49M |
| Change in Other Net Operating Assets | 12.35M | 23.59M | 44.98M | -330.00K | 15.28M | 10.36M |
| Operating Cash Flow | 208.21M | 208.67M | 239.81M | 143.60M | 116.05M | 60.37M |
| Capital Expenditures | -85.00K | -58.00K | -556.00K | -198.52M | -10.03M | -1.02M |
| Sale (Purchase) of Intangibles | -81.51M | |||||
| Investment in Securities | -13.46M | 19.24M | -10.00M | |||
| Investing Cash Flow | -85.00K | -58.00K | -556.00K | -293.50M | 9.21M | -11.02M |
| Issuance of Common Stock | 13.18M | 14.67M | 154.51M | 2.79M | 9.57M | 4.10M |
| Repurchase of Common Stock | -41.31M | -27.07M | -668.00K | -982.00K | -7.14M | -12.24M |
| Other Financing Activities | -4.80M | -4.59M | -13.18M | -12.67M | -738.00K | |
| Financing Cash Flow | -32.93M | -16.99M | 140.66M | -10.86M | 1.69M | -8.14M |
| Net Cash Flow | 175.20M | 191.62M | 379.92M | -160.76M | 126.95M | 41.21M |
| Free Cash Flow | 208.13M | 208.61M | 239.25M | -54.92M | 106.02M | 59.35M |
| Free Cash Flow Margin | 34.87% | 35.42% | 48.66% | -13.79% | 49.49% | 42.14% |
| Free Cash Flow Per Share | 1.64 | 1.64 | 1.92 | -0.48 | 0.95 | 0.55 |
| Levered Free Cash Flow | 171.81M | 171.34M | 201.64M | -219.49M | 89.69M | 42.14M |
| Unlevered Free Cash Flow | 171.81M | 171.34M | 201.64M | -219.49M | 89.69M | 42.14M |
| Cash Interest Paid | 503.00K | 466.00K | 1.40M | 705.00K | ||
| Cash Income Tax Paid | 73.19M | 71.99M | 68.45M | 50.46M | 7.67M | 3.00M |
| Change in Working Capital | -66.88M | -60.90M | 30.91M | -37.32M | 13.73M | 5.02M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.85B | 2.87B | 2.49B | 1.79B | 1.94B | 698.11M |
| Enterprise Value | 3.10B | 2.18B | 2.05B | 1.67B | 1.68B | 527.57M |
| Last Close Price | 31.49 | 23.34 | 20.87 | 16.81 | 18.60 | 6.77 |
| PE Ratio | 18.20 | 13.38 | 15.19 | 25.10 | 23.30 | 17.68 |
| Forward PE | 15.69 | 15.48 | 15.38 | 14.13 | 14.98 | 13.97 |
| PS Ratio | 6.46 | 4.87 | 5.06 | 4.50 | 9.04 | 4.96 |
| PB Ratio | 3.80 | 3.01 | 3.42 | 4.62 | 6.44 | 3.38 |
| P/TBV Ratio | 4.33 | 3.49 | 4.36 | 9.25 | 7.22 | 3.38 |
| P/FCF Ratio | 18.52 | 13.75 | 10.40 | 18.26 | 11.76 | |
| P/OCF Ratio | 18.51 | 13.75 | 10.38 | 12.48 | 16.68 | 11.56 |
| PEG Ratio | 1.26 | 1.31 | 1.15 | |||
| EV/Sales Ratio | 5.20 | 3.70 | 4.17 | 4.21 | 7.86 | 3.75 |
| EV/EBITDA Ratio | 10.14 | 7.38 | 8.80 | 13.99 | 16.33 | 10.03 |
| EV/EBIT Ratio | 11.59 | 8.46 | 10.51 | 19.29 | 16.53 | 10.07 |
| EV/FCF Ratio | 14.90 | 10.46 | 8.57 | 15.88 | 8.89 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.04 | 0.08 |
| Debt / FCF Ratio | 0.01 | 0.01 | 0.01 | 0.04 | 0.07 | |
| Net Debt / Equity Ratio | -0.74 | -0.74 | -0.71 | -0.35 | -0.98 | -0.90 |
| Net Debt / EBITDA Ratio | -2.46 | -2.39 | -2.21 | -1.12 | -2.86 | -3.56 |
| Net Debt / FCF Ratio | -3.62 | -3.39 | -2.15 | 2.44 | -2.78 | -3.15 |
| Asset Turnover | 0.58 | 0.60 | 0.74 | 0.94 | 0.70 | 0.66 |
| Inventory Turnover | 3.48 | 3.53 | 4.63 | 12.93 | 7.38 | 6.20 |
| Quick Ratio | 6.70 | 5.69 | 4.84 | 2.52 | 5.37 | 7.32 |
| Current Ratio | 7.10 | 6.08 | 5.17 | 2.88 | 5.57 | 7.76 |
| Return on Equity (ROE) | 24.50% | 25.49% | 29.38% | 20.75% | 32.76% | 20.98% |
| Return on Assets (ROA) | 16.27% | 16.48% | 18.46% | 12.83% | 20.75% | 15.22% |
| Return on Invested Capital (ROIC) | 78.76% | 84.52% | 63.32% | 50.51% | 629.06% | 159.91% |
| Return on Capital Employed (ROCE) | 26.40% | 26.90% | 26.70% | 22.00% | 32.00% | 24.90% |
| Earnings Yield | 5.74% | 7.47% | 6.58% | 3.98% | 4.29% | 5.66% |
| FCF Yield | 5.40% | 7.27% | 9.61% | -3.06% | 5.48% | 8.50% |
| Buyback Yield / Dilution | -1.12% | -1.85% | -9.84% | -2.14% | -3.32% | -1.46% |